SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,956 | +1.3% | 16,000 | 0.0% | 0.00% | – |
| Q4 2022 | $15,747 | -100.0% | 16,000 | -68.2% | 0.00% | -100.0% |
| Q3 2022 | $1,176,663,000 | +7484.0% | 50,299 | +214.4% | 0.00% | – |
| Q2 2022 | $15,515,000 | -0.8% | 16,000 | 0.0% | 0.00% | – |
| Q1 2022 | $15,633,000 | -1.6% | 16,000 | 0.0% | 0.00% | – |
| Q4 2021 | $15,880,000 | +0.6% | 16,000 | 0.0% | 0.00% | – |
| Q3 2021 | $15,788,000 | -0.2% | 16,000 | 0.0% | 0.00% | – |
| Q2 2021 | $15,827,000 | +2.6% | 16,000 | 0.0% | 0.00% | – |
| Q1 2021 | $15,426,000 | +1.6% | 16,000 | 0.0% | 0.00% | – |
| Q4 2020 | $15,184,000 | +2.8% | 16,000 | 0.0% | 0.00% | – |
| Q3 2020 | $14,775,000 | +4.6% | 16,000 | 0.0% | 0.00% | – |
| Q2 2020 | $14,126,000 | -99.5% | 16,000 | -99.6% | 0.00% | -100.0% |
| Q1 2020 | $2,972,297,000 | – | 3,673,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 45,402,000 | $44,828,000 | 4.21% |
| Radcliffe Capital Management, L.P. | 69,010,000 | $67,802,000 | 1.97% |
| Penn Mutual Asset Management | 675 | $672,000 | 1.06% |
| CAMDEN ASSET MANAGEMENT L P /CA | 24,548,000 | $24,118,000 | 0.95% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,428,000 | $38,079,000 | 0.87% |
| DeepCurrents Investment Group LLC | 21,155,000 | $20,805,000 | 0.62% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,813,000 | $6,618,000 | 0.51% |
| OAKTREE CAPITAL MANAGEMENT LP | 22,348,000 | $22,068,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,540,000 | $16,325,000 | 0.14% |
| AVIVA PLC | 17,300,000 | $16,926,000 | 0.08% |